Laboratorios Farmaceuticos Rovi, S.A. (LON:0ILL)

LON:0ILL Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,797	2,663	2,788	1,707	3,475	1,881
Market Cap Growth	4.77%	-4.50%	63.31%	-50.88%	84.77%	64.28%
Enterprise Value	2,872	2,762	2,797	1,687	3,415	1,916
Last Close Price	54.58	51.23	51.53	30.88	58.24	32.24
PE Ratio	26.45	23.52	18.86	9.64	27.03	34.38
PS Ratio	4.43	4.22	3.87	2.35	6.38	5.00
PB Ratio	5.06	5.54	5.91	3.69	8.79	5.62
P/TBV Ratio	5.47	5.92	6.28	3.92	9.42	6.18
P/FCF Ratio	28.86	40.68	54.04	10.30	37.89	278.47
P/OCF Ratio	18.36	23.29	28.37	8.10	27.69	44.79
EV/Sales Ratio	4.55	4.37	3.89	2.33	6.27	5.09
EV/EBITDA Ratio	18.39	16.73	13.54	7.01	20.69	23.87
EV/EBIT Ratio	21.87	18.69	14.69	7.50	22.57	28.55
EV/FCF Ratio	29.63	42.20	54.22	10.18	37.23	283.73
Debt / Equity Ratio	0.20	0.20	0.12	0.14	0.16	0.20
Debt / EBITDA Ratio	0.69	0.56	0.27	0.26	0.36	0.80
Debt / FCF Ratio	1.11	1.45	1.10	0.39	0.67	9.87
Asset Turnover	0.81	0.94	0.99	1.01	0.99	0.77
Inventory Turnover	0.82	0.89	1.07	1.10	1.14	0.95
Quick Ratio	1.30	0.99	0.83	1.04	1.35	1.10
Current Ratio	3.02	3.13	2.55	2.12	2.66	2.97
Return on Equity (ROE)	20.34%	24.33%	31.99%	40.24%	36.24%	17.54%
Return on Assets (ROA)	10.46%	13.69%	16.34%	19.68%	17.23%	8.63%
Return on Capital (ROIC)	13.05%	17.12%	22.81%	27.88%	22.69%	10.95%
Return on Capital Employed (ROCE)	20.40%	26.50%	36.60%	43.40%	33.20%	16.60%
Earnings Yield	3.78%	4.25%	5.30%	10.37%	3.70%	2.91%
FCF Yield	3.46%	2.46%	1.85%	9.71%	2.64%	0.36%
Dividend Yield	1.06%	1.51%	1.86%	3.72%	1.38%	1.06%
Payout Ratio	39.48%	41.24%	40.54%	25.55%	13.80%	15.89%
Buyback Yield / Dilution	-	3.73%	0.51%	3.50%	-0.03%	-0.37%
Total Shareholder Return	1.06%	5.24%	2.37%	7.21%	1.35%	0.69%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.